The size of the Europe Medical Second Opinion Market is forecasted to grow at a steady CAGR from 2020 to 2025. The major hospital chain collaborations between different European countries are expected to boost the Medical Second Opinion market in this region.
Y-O-Y growth in the incidence of chronic diseases is significantly growing the European Medical Second Opinion Market. People in Europe prefer to opt for a second medical opinion for diseases such as ocular, neurological, pulmonary, and nephrological disorders. The outbreak of COVID-19 extending to rising demand for the second opinion arranged by physicians and health insurance providers. Enhanced healthcare infrastructure and government initiatives, growing investments towards mobile and e-health care systems, and surging involvement of second opinion services for employee benefit plans to drive the market. The telemedicine industry has been growing at a speed of more than 15% and is anticipated to increase at the same rate with rising investments by hospitals, clinics, and venture capitalists. A regular increase of chronic diseases, augmenting prominence on superior treatment results, is to mount the market growth.
The scarcity of knowledge and technological advancements is hindering the market. Moreover, a lack of full knowledge through the processes available options is to impede the market. Stable economies in financial strategies among developed and developing countries may impact the market negatively. Less knowledge and hesitancy in choosing medical second opinion in emerging nations hinder the market.
This research report on the European Medical Second Opinion Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
Europe is the second-largest following North America is leading the medical second opinion market growing significance for healthcare cost enhancements, and growing awareness in people is projected to escalate the growth in the medical second opinion. UK is governing the market, which is predicted to grow with a CAGR of 18.1% sharing in terms of revenue $ 284.7 million. The factors like lessening the monetary cost, increasing the need for advanced diagnosis and treatment planning, and simple interaction are expected to propel the market growth. Also, acceptable government initiatives, advancements in the market like acquisitions, mergers, and collaborations influence the development. Germany is expected to witness a notable shift in the market due to rising health insurance for effective management of health claims, increasing illustrations of medical errors, around 237 million medical errors, and preventable unfavorable drug reactions which lead to hundreds of deaths, according to the National Health Insurance (NHS). Growing medical insurance and increasing acceptance of technology among the contributors is driving the market growth. Mounting exhibition of risk factors like intake of tobacco, extreme alcoholism, unhealthy diet, and obesity is further projected to spur this region's market growth.
Companies dominating the Europe Medical Second Opinion Market Profiled in the report are Amradnet, London Pain Clinic, Johns Hopkins USA, Cynergy Care, Bright Grey Royal London Group, Helsana Group, Mendocino County Mental Health, Hyjiya Digital Wellness FZCO, Penn Medicine.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Disease
5.1.1 Cancer
5.1.2 Cardiac Disorders
5.1.3 Diabetes
5.1.4 Injuries
5.1.5 Y-o-Y Growth Analysis, By Disease
5.1.6 Market Attractiveness Analysis, By Disease
5.1.7 Market Share Analysis, By Disease
5.2 Supply provider
5.2.1 Hospitals
5.2.2 Health Insurance Players
5.2.3 Online and Offline Medical Second Opinion Providers
5.2.4 Private clinics
5.2.5 Y-o-Y Growth Analysis, By Supply provider
5.2.6 Market Attractiveness Analysis, By Supply provider
5.2.7 Market Share Analysis, By Supply provider
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By Indication
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 AXA PPP Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Amradnet
8.3 London Pain Clinic
8.4 Johns Hopkins USA
8.5 Cynergy Care
8.6 Bright Grey, Royal London Group
8.7 Helsana Group
8.8 Mendocino County Mental Health
8.9 Hyjiya Digital Wellness FZCO
8.10 Penn Medicine
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
